Topics
- How to create better and safer methods for treating cardiovascular disease?
- What is the impact on clinical practice?
- How should we interpret the results of the major recent trials?
- How can we improve operating procedures and streamline trial execution?
- How can we design and conduct better and cheaper trials that address true unmet needs?
- How to operate within the regulatory environment? Foster cross-talk with regulatory agencies?
Who should Attend
Clinical trialists, opinion leaders, regulators, investigators, statisticians, industry R&D experts, decision makers and practitioners from over 30 different countries.
